What one share of Alector holds
We are a clinical-stage biotechnology company developing therapies for neurodegenerative diseases, with a focus on areas of high unmet medical need. Our work is informed by advances in disease biology, including the roles of misfolded or deficient proteins, lysosomal dysfunction, and immune and neuronal pathway disruption.
Alector’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.09 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.46 |
| Cash and investments | $1.55 |
| Debt | $0.09 |
| Book value | −$0.09 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.41 | −$3.55 | $0.09 | −$2.03 | — | −$5.69 |
| 2018 | $2.45 | −$4.62 | $0.17 | $11.11 | — | −$7.08 |
| 2019 | $0.34 | −$1.71 | $0.25 | −$1.86 | — | $2.82 |
| 2020 | $0.27 | −$2.45 | $0.06 | −$2.21 | — | $3.37 |
| 2021 | $2.58 | −$0.45 | $0.04 | $3.67 | — | $3.67 |
| 2022 | $1.62 | −$1.62 | $0.05 | −$0.30 | — | $2.59 |
| 2023 | $1.16 | −$1.56 | $0.03 | −$2.23 | — | $1.58 |
| 2024 | $1.04 | −$1.23 | $0.01 | −$2.39 | — | $1.28 |
| 2025 | $0.20 | −$1.39 | $0.00 | −$1.79 | — | $0.28 |
Common questions about Alector
How much does one share of Alector earn?
Over the last 12 months, Alector lost $1.09 for each share.
Does Alector pay a dividend?
Alector didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Alector’s book value per share?
Alector’s book value is negative (−$0.09 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Alector have?
Each share of Alector has $1.55 of cash and investments and $0.09 of debt, as of June 30, 2026.
What is Alector’s free cash flow per share?
−$1.46 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Alector bought back shares?
Alector’s share count rose about 1027% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.